Literature DB >> 15170427

[Trial of labor in moderate pelvic dystocia at Dakar University Teaching Hospital].

C-T Cissé1, C Kokaina, O Ndiaye, J-C Moreau.   

Abstract

OBJECTIVE: To study frequency of moderate pelvic dystocia, to evaluate the diagnosis value of clinical pelvic evaluation and prognosis of trial labor with only clinical monitoring. MATERIAL AND
METHOD: This is a prospective, exposed and non-exposed study concerning 296 women selected among deliveries presenting moderate pelvic dystocia recorded at Dakar University Teaching Hospital from February 1st 2001 to July 31 2002. Trial labor was undertaken in 148 patients; the control group was chosen among women who underwent prophylactic caesarean section and had no other risk factors of maternal and perinatal complications. Pearson's chi-square test was used or statistic analysis with p value 5% and test of Kappa.
RESULTS: Moderate pelvic dystocia was observed 5.3 per 100 deliveries. The most common epidemiological profile was primipara, young age (mean 24 years), height 161 cm (mean), 38-week pregnancy (mean). Clinical evaluation had good diagnosis value comparable with the radiological pelvimetry. Trial labor was undertaken in 148 women, 109 trials (73.6%) were successful; vaginal delivery rate was 27% in women with moderate pelvic dystocia. There were no maternal deaths, maternal morbidity was 4% in trial labor patients and 2.7% in prophylactic caesarean section patents (mainly infection). Post-natal mortality was 7.4% after trial of labour versus 4.1% of newborn child after prophylactic caesarean.
CONCLUSION: These results confirm that trial of labor on moderate pelvic dystocia should be the rule whenever possible, even when only clinical monitoring is available.

Entities:  

Mesh:

Year:  2004        PMID: 15170427     DOI: 10.1016/s0368-2315(04)96460-5

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  1 in total

1.  Contribution of Scanopelvimetry in the Prognosis of Childbirth.

Authors:  Lova Hasina Rajaonarison Ny Ony Narindra; Christian Tomboravo; Honjaniaina Rasolohery; Emmylou Prisca Gabrielle Andrianah; Gabriel Pierana Randaoharison; Ahmad Ahmad
Journal:  Cureus       Date:  2018-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.